Loukas Settas

Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed

L.B.A. van de Putte, Michel Malaise, J Sany et al. · Annals of the Rheumatic Diseases · 2004 · 617 citations · Full text

Comparative effectiveness and survival of infliximab, adalimumab, and etanercept for rheumatoid arthritis patients in the Hellenic Registry of Biologics: Low rates of remission and 5-year drug survival

Irini Flouri, Theodora E. Markatseli, Paraskevi V. Voulgari et al. · Seminars in Arthritis and Rheumatism · 2013 · 92 citations

Rheumatoid Disorder, Rheumatology, Medicine +10

Impaired Fibrinolysis as an Essential Contribution to Thrombosis in Patients with Lupus Anticoagulant

Dimitrios Α. Tsakiris, G A Marbet, P.E. Makris et al. · Thrombosis and Haemostasis · 1989 · 71 citations

Impaired Fibrinolysis, Immunology, Pathology +22

Clinical expression and morbidity of systemic lupus erythematosus during a post-diagnostic 5-year follow-up: a male:female comparison

S Stefanidou, Alexis Benos, Vasiliki Galanopoulou et al. · Lupus · 2011 · 70 citations

Guidelines for initiation of anti-tumour necrosis factor therapy in rheumatoid arthritis: similarities and differences across Europe

Paul Emery, Ronald van Vollenhoven, M. Østergaard et al. · Annals of the Rheumatic Diseases · 2009 · 57 citations